Single dose of AZD7442 effectively prevents COVID-19
Apr 22, 2022
A relative risk reduction of 82.8% was seen in symptomatic COVID-19 at extended follow-up of a median of six months.
Assisted living providers prohibited from denying employee COVID vaccine exemption requests
By
Kimberly Bonvissuto
Apr 22, 2022
An amendment to an existing state law expands protections for employees subject to employer COVID-19 vaccine mandates, further complicating the pandemic landscape for assisted living providers in Tennessee.
Early effectiveness assessed for fourth dose of BNT162b2 vaccine
Apr 21, 2022
The difference in absolute risk for three versus four doses was 180.1 and 68.8 cases per 100,000 for COVID-19-related hospitalization and severe COVID-19.
COVID-19 response coordinator says adults older than 60 should get second booster
Apr 18, 2022
The FDA authorized a second booster of the Pfizer and Moderna vaccines on March 29 for anyone 50 years and older.
Third mRNA COVID-19 vaccine dose appears to be safe
Apr 15, 2022
There were higher reports of low-severity adverse effects but no change in severe events.
COVID-19 booster compliance among long-term care workers remains low
By
Kathleen Steele Gaivin
Apr 15, 2022
New Jersey Gov. Phil Murphy (D) this week clarified that long-term care and other healthcare workers in the state satisfy the state’s vaccination requirements once they obtain one booster dose of a COVID-19...
To boost or not to boost: that is the question
By
Kimberly Bonvissuto
Apr 14, 2022
Without federal health and regulatory agencies taking a strong position on a second COVID-19 booster shot, confusion abounds over who should get boosted, and when.
Vaccination offers extra protection after SARS-CoV-2 infection
Apr 06, 2022
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination.
FDA panel meets to craft future vaccine strategy
Apr 06, 2022
No official vote is planned, and no specific vaccine products will be discussed.
Risk for acute MI not increased with two-dose HepB-CpG vaccine
Apr 01, 2022
The noninferiority study shows no increased risk for acute myocardial infarction with the two-dose HepB-CpG vaccine versus the three-dose HepB-alum vaccine.